Which pharmaceutical companies have the most SPCs in Austria?

The chart identifies pharmaceutical companies with the most Supplementary Protection Certificates (SPCs) in Austria, which encourage drug innovation by allowing for compensation due to the lengthy regulatory approval process. SPCs only become active after the general patent has expired, usually having a maximum lifespan of five years. The combined duration of patent and SPC exclusivity normally cannot exceed 15 years, although a six-month extension can be requested for pediatric trials.